Orgaran and Kytril drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Orgaran (danaparoid sodium) and Kytril (granisetron hydrochloride). Common drug interactions include febrile neutropenia among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Orgaran and Kytril. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Orgaran?
Orgaran has active ingredients of danaparoid sodium. eHealthMe is studying from 863 Orgaran users. Check the latest studies of Orgaran.
What is Kytril?
Kytril has active ingredients of granisetron hydrochloride. eHealthMe is studying from 10,766 Kytril users. Check the latest studies of Kytril.
21 people who take Orgaran and Kytril together, and have interactions are studied.

What are the common drug interactions of Orgaran and Kytril, by gender? *:
female:
- Febrile neutropenia (fever with reduced white blood cells)
- Platelet count decreased
- White blood cell count decreased
- Anaemia (lack of blood)
- Bacteraemia (presence of bacteria in the blood)
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
- C-reactive protein increased
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Diarrhoea
- Fungaemia (fungi circulate in the blood)
male:
- Diarrhoea
- Pyrexia (fever)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Oedema (fluid collection in tissue)
- Septic shock (shock due to blood infection)
- Vomiting
- Adenovirus infection
- Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
- Bacteraemia (presence of bacteria in the blood)
- Bk virus infection
What are the common drug interactions of Orgaran and Kytril, by age (0-1 to 60+)? *:
0-1:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Diarrhoea
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Oedema (fluid collection in tissue)
- Pyrexia (fever)
2-9:
- Diarrhoea
- Febrile neutropenia (fever with reduced white blood cells)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Vomiting
- Bacteraemia (presence of bacteria in the blood)
- Pyrexia (fever)
- Anaemia (lack of blood)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Platelet count decreased
10-19:
n/a
20-29:
n/a
30-39:
- Septic shock (shock due to blood infection)
40-49:
n/a
50-59:
- C-reactive protein increased
- Fungaemia (fungi circulate in the blood)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
60+:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Pulmonary haemorrhage (acute bleeding from the lung)
- Blood pressure decreased
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- C-reactive protein increased
- Cardiac arrest
- Cellulitis (infection under the skin)
- Coma (state of unconsciousness lasting more than six hours)
- Depressed level of consciousness
- Febrile neutropenia (fever with reduced white blood cells)
What are the existing conditions these people have? *
- Bone Marrow Conditioning Regimen: 7 people, 33.33%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 28.57%
- Immunodeficiency Disorders: 5 people, 23.81%
- Pain: 4 people, 19.05%
- Allergies: 4 people, 19.05%
- Bacteraemia (presence of bacteria in the blood): 3 people, 14.29%
- Cough: 2 people, 9.52%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 9.52%
- Bacterial Infection: 2 people, 9.52%
- Urination - Excessive Volume: 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Orgaran and Kytril?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Orgaran and Kytril:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Orgaran:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Kytril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Orgaran and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Kytril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on danaparoid sodium and granisetron hydrochloride (the active ingredients of Orgaran and Kytril, respectively), and Orgaran and Kytril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cannabis Sativa and Sevoflurane - a second ago
- Could Paroxetine Hydrochloride cause Eye Movement Disorder? - 15 seconds ago
- Could Imodium cause Hepatic Cyst? - 16 seconds ago
- Could Ceftazidime cause Haematochezia? - 23 seconds ago
- Insomnia and Headache - 26 seconds ago
- Could Lansoprazole cause Chemotherapy? - 32 seconds ago
- Could Ranitidine cause Raynaud'S Phenomenon? - 50 seconds ago
- Drug interactions of Profen and Gengraf - a minute ago
- Drug interactions of Skelaxin and Aspirin - a minute ago
- Drug interactions of Onglyza and Apresoline - a minute ago